Diagnostics makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Becton DickinsonLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 16, 2026, FDA's public records list Becton Dickinson Microbiology Systems with 33 510(k) clearances. The most recent is a 510(k) clearance dated Dec 1, 1999: CEFOTAXIME/CLAVULANIC, 30/10UG, BBL SENSI-DISC AND CEFTAZIDIME/CLAVULANIC ACID, 30/10UG,….
| Dec 1, 1999 | CEFOTAXIME/CLAVULANIC, 30/10UG, BBL SENSI-DISC AND CEFTAZIDIME/CLAVULANIC ACID, 30/10UG, BBL SENSI-DISCK993577 · JTN | 510(k) clearances |
| Nov 4, 1999 | BDPROBETEC ET CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE AMPLIFIED DNA ASSAYK984631 · LSL | 510(k) clearances |
| Jun 9, 1998 | CEFDINIR, 5 UG, SENSI-DISCK981517 · JTN | 510(k) clearances |
| May 1, 1998 | TROVAFLOXACIN 10G, SENSI-DISCK980683 · JTN | 510(k) clearances |
| Feb 23, 1998 | GREPAFLOXACIN, 5 MG, SENSI-DISCK974578 · JTN | 510(k) clearances |
| Jan 28, 1998 | BACTEC MYCO/F LYTIC CULTURE VIALSK970333 · MDB | 510(k) clearances |
| Jan 8, 1998 | BACTEC MYCO/F LYTIC CULTURE VIALSK970512 · MDB | 510(k) clearances |
| Aug 8, 1997 | BACTEC MYCO/F-SPUTA CULTURE VIALSK972758 · MDB | 510(k) clearances |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built